SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD. – Trademark Portfolio
Entity Type: 99
SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include POPEGO. The owner is based in SHENZHEN.
ROOM 301, BUILDING F12, F518 FASHION CREATIVE PARK, NO. 1065, BAOYUAN
ROAD, LAODONG COMMUNITY, XIXIANG STREET, BAO'AN DISTRICT,
SHENZHEN , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD. have?
SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD. file in?
SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD.'s most well-known trademarks?
SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD.'s registered trademark portfolio includes well-known marks such as POPEGO. These are among 1 currently registered trademark in the portfolio.
What is SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD.'s trademark registration success rate?
SHENZHEN XIAOYAOYOU INFORMATION NETWORK CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.